Laura Andres-Martin, PhD
Senior Research Investigator, Oncology at NYSCF
2015 NYSCF – Druckenmiller Fellow Alumna
PhD, University of Salamanca, Spain
Bio
Dr. Andres-Martin received her PhD from the University of Salamanca in Spain, studying tyrosine kinase receptor signaling in cancer and rare diseases. She then served as a postdoc at Weill Cornell Medicine, focusing on tyrosine kinase receptor signaling in neurodegenerative disorders and stem cell biology. In 2015, she received the New York Stem Cell Foundation Drunckenmiller fellowship, which supported her research examining the mechanism-driving stem cell competition in the paternal germline and its contribution to rare diseases, neurodevelopmental disorders, and cancer. As a senior staff scientist in oncology at NYSCF, she will be using organoids as a platform for developing diagnostics, performing genomic screenings, and discovering new therapeutics.
Watch top researchers discuss women’s reproductive cancers, stem cells, and improving outcomes for patients.
External Links
Research Area
Mentioned In
- Listen Up: NYSCF Talks Technology, Community, and DEIB with The Stem Cell Podcast
- NYSCF Community Showcased at the International Society for Stem Cell Research Conference
- Translating Discoveries into Medicine, Advancing Equity in Science, and New Cancer Therapies: Watch Highlights of the 2021 NYSCF Conference
- The Stem Cell Science You Won’t Want to Miss at The NYSCF Conference
- On the Road to Personalized Therapies for Women with Reproductive Cancers
- Precision Medicine and the Power of Stem Cells: Highlights of the 2019 NYSCF Conference